Astrana Health, Inc.
ASTH
$29.34
$0.1450.50%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.75M | 1.60M | 4.08M | 6.39M | 9.90M |
| Total Other Revenue | 475.96M | 484.66M | 400.28M | 346.65M | 338.28M |
| Total Revenue | 478.71M | 486.27M | 404.36M | 353.04M | 348.17M |
| Cost of Revenue | 405.22M | 412.81M | 330.40M | 314.06M | 275.38M |
| Gross Profit | 73.49M | 73.46M | 73.96M | 38.98M | 72.80M |
| SG&A Expenses | 37.80M | 35.95M | 38.72M | 37.95M | 29.41M |
| Depreciation & Amortization | 7.26M | 7.44M | 5.10M | 4.90M | 4.31M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 450.29M | 456.20M | 374.22M | 356.91M | 309.09M |
| Operating Income | 28.43M | 30.07M | 30.14M | -3.87M | 39.08M |
| Income Before Tax | 26.81M | 31.90M | 24.00M | 924.00K | 38.02M |
| Income Tax Expenses | 7.83M | 10.03M | 7.14M | 1.02M | 10.04M |
| Earnings from Continuing Operations | 18.98M | 21.87M | 16.86M | -94.00K | 27.97M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -2.89M | -2.70M | -2.03M | 12.45M | -5.91M |
| Net Income | 16.09M | 19.17M | 14.84M | 12.36M | 22.06M |
| EBIT | 28.43M | 30.07M | 30.14M | -3.87M | 39.08M |
| EBITDA | 35.69M | 37.51M | 35.24M | 1.03M | 43.39M |
| EPS Basic | 0.34 | 0.40 | 0.31 | 0.26 | 0.47 |
| Normalized Basic EPS | 0.27 | 0.36 | 0.26 | 0.24 | 0.39 |
| EPS Diluted | 0.33 | 0.40 | 0.31 | 0.26 | 0.47 |
| Normalized Diluted EPS | 0.27 | 0.36 | 0.26 | 0.24 | 0.38 |
| Average Basic Shares Outstanding | 47.69M | 47.62M | 47.26M | 47.52M | 46.55M |
| Average Diluted Shares Outstanding | 48.22M | 47.98M | 47.70M | 47.52M | 46.92M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | 484.04% | 10.27% |
